{"id":140501,"date":"2024-12-11T12:47:32","date_gmt":"2024-12-11T07:17:32","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=140501"},"modified":"2024-12-11T12:47:34","modified_gmt":"2024-12-11T07:17:34","slug":"pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/","title":{"rendered":"Pharma stock in focus after commissioning new manufacturing plant in Maharashtra"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3286723945\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>In Wednesday\u2019s trading session, the shares of one of the leading pharmaceutical companies in India surged by 2.5 percent day&#8217;s trade after commissioning of&nbsp; a new production block at its Ambernath unit in Maharashtra, India with a Capex plan of&nbsp; Rs. 10 Crores.<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2867028669\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Price action<\/strong><\/h2><p>With a market capitalization of 8,714.9 Crores on Wednesday, the shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/BLUEJET\" target=\"_blank\" rel=\"noreferrer noopener\">Blue Jet Healthcare Ltd <\/a><\/strong>rose by 2.5 percent making a high of Rs 518.65 compared to its previous closing price of Rs 503.50.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>What happened<\/strong><\/h2><p>Blue Jet Healthcare Ltd surged on Wednesday following the commissioning of&nbsp; a new production block at its Ambernath unit in Maharashtra. The new facility will focus on manufacturing advanced contrast media, which is essential for medical imaging.&nbsp;<\/p><p>The company has an existing capacity of 1,140.90 KL with the current utilization rate of approximately 70 percent following which the company plans to expand its production by an additional 37.6 KL over the next three months with an investment of Rs. 10 Crores approximately for expansion, which will be financed through the company&#8217;s internal accruals.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-2978912593\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>This development is part of Blue Jet Healthcare\u2019s broader strategy to strengthen its manufacturing capabilities and meet the increasing demand for advanced contrast media in the market.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the company<\/strong><\/h2><p>Blue Jet Healthcare Ltd specialises in the development and manufacturing of high-quality contrast media intermediaries, High intensity Sweeteners and Pharma Intermediates &amp; APIs and other healthcare products with a focus on delivering advanced, safe and effective products to meet the growing demands of the healthcare sector.&nbsp;<\/p><p>With a strong presence in the healthcare industry, the company is committed to providing innovative solutions that support medical imaging and diagnostic processes,Through continuous research and development, along with state-of-the-art manufacturing facilities, the company aims to enhance its capabilities and expand its reach in the global market.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financials&nbsp;<\/strong><\/h2><p>The company&#8217;s revenue rose by 16.23 percent from Rs 189.56 crore in Q2FY24 to Rs 220.33 crore in Q2FY25. Meanwhile, Net profit rose by 21.89 percent from Rs 47.87 crores to Rs 58.35 crore during the same period.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Key Financial ratios<\/strong><\/h2><p>Blue Jet Healthcare Ltd has an impressive&nbsp; Return on Equity (RoE) of 18&nbsp; percent and a Return on Capital Employed (RoCE) of 24 percent and PE ratio of 50. Furthermore, the company&#8217;s debt-to-equity ratio is 0.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Shareholding Pattern<\/strong><\/h2><p>Blue Jet Healthcare Ltd. has a well-diversified shareholding structure. As of September 2024, The promoters hold 86 percent, while Foreign Institutional Investors (FIIs) own 2.18 percent and Domestic Institutional Investors (DIIs) hold 1.74 percent. The remaining 10.07 percent is owned by the public, It reflects a balanced mix of promoter control and investor confidence from both institutional and retail shareholders.<\/p><div class=\"trade-content-10\" id=\"trade-3656370480\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Stock Performance<\/strong><\/h2><p>The stock has provided returns of about 48.17 percent over the last year, along with a 31 percent&nbsp; gain in the past six months of 2024, it has continued to perform strongly.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Sridhar<\/strong><\/p><\/blockquote><h2 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h2><div class=\"wp-block-image\"><figure class=\"aligncenter\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on&nbsp;<a href=\"https:\/\/tradebrains.in\/\">tradebrains.in<\/a>&nbsp;are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-1435170376\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>In Wednesday\u2019s trading session, the shares of one of the leading pharmaceutical companies in India surged by 2.5 percent day&#8217;s trade after commissioning of&nbsp; a new production block at its Ambernath unit in Maharashtra, India with a Capex plan of&nbsp; Rs. 10 Crores. Price action With a market capitalization of 8,714.9 Crores on Wednesday, the [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[25321,25322,15654,948,936],"class_list":["post-140501","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-blue-jet-healthcare","tag-blue-jet-healthcare-latest-news","tag-pharma-stock-news","tag-stock-market","tag-stock-market-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock in focus after commissioning new manufacturing plant in Maharashtra - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"In Wednesday\u2019s trading session, the shares of one of the leading pharmaceutical companies in India surged by 2.5 percent day&#039;s trade after commissioning of\u00a0 a new production block at its Ambernath unit in Maharashtra, India with a Capex plan of\u00a0 Rs. 10 Crores.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock in focus after commissioning new manufacturing plant in Maharashtra\" \/>\n<meta property=\"og:description\" content=\"In Wednesday\u2019s trading session, the shares of one of the leading pharmaceutical companies in India surged by 2.5 percent day&#039;s trade after commissioning of\u00a0 a new production block at its Ambernath unit in Maharashtra, India with a Capex plan of\u00a0 Rs. 10 Crores.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-11T07:17:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-11T07:17:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/\",\"name\":\"Pharma stock in focus after commissioning new manufacturing plant in Maharashtra - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2024-12-11T07:17:32+00:00\",\"dateModified\":\"2024-12-11T07:17:34+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"In Wednesday\u2019s trading session, the shares of one of the leading pharmaceutical companies in India surged by 2.5 percent day's trade after commissioning of\u00a0 a new production block at its Ambernath unit in Maharashtra, India with a Capex plan of\u00a0 Rs. 10 Crores.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock in focus after commissioning new manufacturing plant in Maharashtra\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock in focus after commissioning new manufacturing plant in Maharashtra - Trade Brains Features","description":"In Wednesday\u2019s trading session, the shares of one of the leading pharmaceutical companies in India surged by 2.5 percent day's trade after commissioning of\u00a0 a new production block at its Ambernath unit in Maharashtra, India with a Capex plan of\u00a0 Rs. 10 Crores.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock in focus after commissioning new manufacturing plant in Maharashtra","og_description":"In Wednesday\u2019s trading session, the shares of one of the leading pharmaceutical companies in India surged by 2.5 percent day's trade after commissioning of\u00a0 a new production block at its Ambernath unit in Maharashtra, India with a Capex plan of\u00a0 Rs. 10 Crores.","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-12-11T07:17:32+00:00","article_modified_time":"2024-12-11T07:17:34+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/","name":"Pharma stock in focus after commissioning new manufacturing plant in Maharashtra - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2024-12-11T07:17:32+00:00","dateModified":"2024-12-11T07:17:34+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"In Wednesday\u2019s trading session, the shares of one of the leading pharmaceutical companies in India surged by 2.5 percent day's trade after commissioning of\u00a0 a new production block at its Ambernath unit in Maharashtra, India with a Capex plan of\u00a0 Rs. 10 Crores.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-commissioning-new-manufacturing-plant-in-maharashtra\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock in focus after commissioning new manufacturing plant in Maharashtra"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/140501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=140501"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/140501\/revisions"}],"predecessor-version":[{"id":140502,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/140501\/revisions\/140502"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=140501"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=140501"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=140501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}